Pi-Cardia, a developer of non-implant catheter-based solutions to treat heart valve calcification, has closed a US$27m venture round of financing, led by Sofinnova Partners and company chairman Jacques Séguin, with further participation from existing investors. “We are excited to join Pi-Cardia as an investor to help leverage the Leaflex [catheter] in building a significant new…
Home Healthcare Markets International Business Israel: Pi-Cardia raises US$27m venture round of funding